Venous Thromboembolism (VTE)

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis

Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted Central Catheter (PICC)

Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism

Precision Antithrombotic Therapy

Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism

Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk

Molecular Imaging of Active Venous Thrombus With Positron Emission Tomography (PET)

Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP).

3D-EIT for Diagnosis and Monitoring of Pulmonary Embolism

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

Design and Rationale of the COLT Study

Duke Virtual IntEgrated Workflow

Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin

Delivery and Implementation of a Randomised Crossover Trial on Thrombosis

External Validation of the CLOVER Score for Detecting Occult Cancer in Venous Thromboembolism Patients

Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer

Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention